GSK2190915(936350-00-4)
- Name: GSK2190915
- Synonyms:GSK2190915;GSK2190915 (AM803);fiboflapon;AM 803;3-[(1,1-Dimethylethyl)thio]-1-[[4-(6-ethoxy-3-pyridinyl)phenyl]methyl]-alpha,alpha-dimethyl-5-[(5-methyl-2-pyridinyl)methoxy]-1H-indole-2-propanoic acid
- Molecular Formula:C38H43N3O4S
- Molecular Weight:637.843
- CAS Registry Number:936350-00-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.936350-00-4 GSK2190915
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:GSK2190915
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.936350-00-4 Fiboflapon;936350-00-4
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.936350-00-4 GSK2190915
Assay:98% Appearance:white powder Package:5mg Storage:Keep it in dry,shady and cool place Transportation:by express or by sea Application:Pharma;Industry;Agricultural;chemical reaserch
Min. Order:0
Supplier:Shanghai Yuanye Bio-Technology Co., Ltd. [
China (Mainland)] CAS No.936350-00-4 GSK2190915
Assay:>98% Package:inquiry Transportation:inquiry Application:GSK2190915 is a potent FLAP(5-Lipoxygenase-activating protein) inhibitor. It exhibits excellent preclinical toxicology and pharmacokinetics in rat and dog. It also demonstrated an extended pharmac...
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 60828-50-4/N-[2-(3,4-dimethoxyphenyl)ethyl]-10b-hydroxy-3,6-dioxo-2,5-di(propan-2-yl)octahydro-8H-[1,3]oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine-2-carboxamide
- 5779-29-3/1-{[(5-amino-1H-tetrazol-1-yl)acetyl]amino}-N-(4-methoxyphenyl)cyclohexanecarboxamide
- 947320-08-3/Methyl 4-isopropylpicolinate
- 143393-03-7/S-3-P TrisodiuM
- 1301754-03-9/5-CHLORO-4-NITRO-1H-PYRAZOLE-3-CARBOXYLIC ACID
- 1174322-70-3/methyl 5-(methylthio)pyrazine-2-carboxylate
- 168915-20-6/2-Imidazolidinethione,1-(hydroxymethyl)-3-methyl-(9CI)
- 49694-21-5/Xylohexaose
- 55821-20-0/6,7-Dimethyl-3-(4-nitrophenyl)-2,4-dioxabicyclo[3.2.1]octane
- 76780-98-8/2-chloro-N-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine(SALTDATA: FREE)
- 899354-59-7/2-AMINO-4-(3,4,5-TRIMETHOXYPHENYL)-5-THIAZOLECARBOXYLIC ACID ETHYL ESTER
- 1132088-63-1/Valganciclovir-d8
- 35490-53-0/3β-Methoxy-4,4-dimethylcholest-5-ene
- 201402-98-4/Decahydro-3soquinolineCarboxamideMonoBenzoate,NelfinavirMesylate,
- 898774-04-4/3',4'-DICHLORO-3-(2-METHOXYPHENYL)PROPIOPHENONE
- 1142191-57-8/2,5-Dibromo-3-methoxypyridine
- 14949-18-9/21-Nor-5α-cholest-24-en-20-one
- 1364663-43-3/tert-butyl 3-(tert-butoxycarbonylaMino)-3-cyanopyrrolidine-1-carboxylate
- 960299-84-7/2-fluoro-4-(pyridin-2-ylamino)phenol
- 936350-00-4/GSK2190915
- 1211530-05-0/6-Chloro-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid
- 20045-36-7/PROSTAGLANDIN E1-[5,6-3H(N)]
- 1173023-53-4/NOB-13C6
- 381725-55-9/2H-Quinolizin-2-ol, octahydro-, (2R,9aS)- (9CI)
- 1630984-19-8/(S)-1-(Naphthalen-2-yl)ethanamine hydrochloride
- 35562-79-9/3,3-Dimethyl-1,4-oxathiepan-2-one
- 1187016-44-9/N-(3-(benzyloxy)-2-(4-(methylsulfonyl)phenyl)-4-oxo-4H-chromen-6-yl)acetamide
- 1216720-69-2/7H-Pyrrolo[3,2-f]quinazoline-1,3-diaMine, N3-cyclopropyl-7-[[4-(1-Methylethyl)phenyl]Methyl]-, (Hydrochloride) (1:2)
- 176849-91-5/4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-iodo-2-methoxybenzamide
- 55401-43-9/(20R)-3α-[(5,5-Dimethyl-3-oxo-1-cyclohexen-1-yl)amino]-20-hydroxypregn-5-en-18-oic acid γ-lactone